Pan‐cancer gene set enrichment analysis (GSEA) was then conducted, revealing a significant positive association between DCTN2 and oncogenic pathways, such as epithelial‐mesenchymal transition (EMT), MYC_TARGETS and DNA_REPAIR but a negative correlation with INTERFERON_ALPHA_RESPONSE and INTERFERON_GAMMA_RESPONSE pathways (Figure 2A). This evidence concerns the gene DCTN2 and cancer.